Full Text View
Tabular View
No Study Results Posted
Related Studies
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers
This study has been completed.
Study NCT00002752   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: August 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Cancer
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Neoplasm Metastasis
Nervous System Neoplasms
More general conditions related to this trial
Neoplasms
Neoplasms by Site
Neoplastic Processes
Nervous System Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Duke University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services